University of Pennsylvania Perelman School of Medicine — Philadelphia, Pennsylvania

University of Pennsylvania Perelman School of Medicine is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Pennsylvania Perelman School of Medicine has participated in 27 clinical trials with 8 currently active.

Therapeutic areas: Hepatocellular Carcinoma, Metastatic Castration Resistant Prostate Cancer, Renal Cell Carcinoma.

Sponsors: Tempest Therapeutics, Sequenom, Inc., University of Pennsylvania.

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Pennsylvania Perelman School of Medicine?

University of Pennsylvania Perelman School of Medicine has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Pennsylvania Perelman School of Medicine conducted?

University of Pennsylvania Perelman School of Medicine has 27 clinical trials on record, with 8 currently active. Their work covers Hepatocellular Carcinoma, Metastatic Castration Resistant Prostate Cancer, Renal Cell Carcinoma.

Is University of Pennsylvania Perelman School of Medicine accredited by Crixeo Health?

Yes — University of Pennsylvania Perelman School of Medicine holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Pennsylvania Perelman School of Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.